<DOC>
	<DOC>NCT01216254</DOC>
	<brief_summary>The aim of this study is to assess the outcomes of breast conserving therapy operation depending on the type of surgical tool used: classic electrocoagulation with higher operative temperatures and high frequency electrocoagulation with lower operative temperatures. The investigators would assess the pain levels, length and amount of the lymphatic secretion as well as quality of life following breast conserving surgery.</brief_summary>
	<brief_title>Clinical Trial Comparing Outcomes of Breast Conserving Operations With Classic v High-frequency Electrocoagulation</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>female age 18100 breast cancer stage IIA and II B (cT1a3; cN01; cM0) no previous breast surgery no previous cancer obtained informed consent stages I, III, IV localised breast infection previous breast surgery for any cause previous cancer no voluntary consent</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>breast cancer</keyword>
	<keyword>stage 2</keyword>
	<keyword>breast conserving therapy</keyword>
	<keyword>sentinel lymph node dissection</keyword>
	<keyword>high frequency electrocoagulation</keyword>
</DOC>